In a new study, a drug originally developed to treat neurological diseases—called URMC-099—protected mice from non-alcoholic fatty liver disease, which is caused by a high-fat diet. Researchers designed the diet they fed the mice to replicate the Western fast food diet and recreate the features of non-alcoholic fatty liver disease found in people. The drug was well tolerated and the research team plans further testing in order to move URMC-099 into early phase human trials...
To read the full story, visit: Futurity
Article: Mixed-lineage kinase 3 pharmacological inhibition attenuates murine nonalcoholic steatohepatitis
Kyoko Tomita, Burns C. Blaxall, Samar H. Ibrahim Published August 3, 2017
Citation Information: JCI Insight. 2017;2(15):e94488. doi:10.1172/jci.insight.94488.
New study evaluates efficacy of PET imaging to manage chronic liver diseases
EASL governing board announces new Vice-Secretary
A web-based program is as effective as group counseling for patients with non-alcoholic fatty liver disease